Article Text
Statistics from Altmetric.com
I read with interest the article by Broughton et al1 and wish to offer the following comments.
(1) The duration of oxygen therapy (in both table 1 and the text) ranges from 30 to 107 weeks, thus qualifying every baby in the cohort as having bronchopulmonary dysplasia (BPD). Even if this was in days, it would make every baby oxygen dependent 28 days after birth compared with 19% in other studies.2
(2) The rate of BPD in this cohort was 40%, which is much higher than has been reported for babies of similar gestation in recent years.2,3 In view of this high rate of BPD and prolonged oxygen dependency, the studied cohort might have consisted of rather sick infants.
(3) Since discharge home …
Footnotes
Competing interests: The author has previously questioned the cost effectiveness of palivizumab in relation to its recommended indications.
Footnotes
Competing interests: none declared.